SM and immune checkpoint blockade combination therapy was associated with increased expansion of CD8+ T cells, a decrease in Treg numbers and increased sensitivity of the tumours to TNF-induced cell death mediated through the RIPK1-Fadd-Caspase8 complex. The gene discussed is CD8A; the disease is neoplasm.